BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11428924)

  • 1. Discovery of novel mesangial cell proliferation inhibitors using a three-dimensional database searching method.
    Kurogi Y; Miyata K; Okamura T; Hashimoto K; Tsutsumi K; Nasu M; Moriyasu M
    J Med Chem; 2001 Jul; 44(14):2304-7. PubMed ID: 11428924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacophore modeling and three-dimensional database searching for drug design using catalyst.
    Kurogi Y; Güner OF
    Curr Med Chem; 2001 Jul; 8(9):1035-55. PubMed ID: 11472240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The discovery of novel vascular endothelial growth factor receptor tyrosine kinases inhibitors: pharmacophore modeling, virtual screening and docking studies.
    Yu H; Wang Z; Zhang L; Zhang J; Huang Q
    Chem Biol Drug Des; 2007 Mar; 69(3):204-11. PubMed ID: 17441906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel farnesyl protein transferase inhibitors using three-dimensional database searching methods.
    Kaminski JJ; Rane DF; Snow ME; Weber L; Rothofsky ML; Anderson SD; Lin SL
    J Med Chem; 1997 Dec; 40(25):4103-12. PubMed ID: 9406600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiazole and thiadiazole analogues as a novel class of adenosine receptor antagonists.
    van Muijlwijk-Koezen JE; Timmerman H; Vollinga RC; Frijtag von Drabbe Künzel J; de Groote M; Visser S; IJzerman AP
    J Med Chem; 2001 Mar; 44(5):749-62. PubMed ID: 11262085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, characterization and biological activity of some 1, 3, 4-thiadiazol derivatives.
    Singh AK; Lohani M; Singh UP
    Pak J Pharm Sci; 2011 Oct; 24(4):571-4. PubMed ID: 21959823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacophore modeling and three dimensional database searching for drug design using catalyst: recent advances.
    Güner O; Clement O; Kurogi Y
    Curr Med Chem; 2004 Nov; 11(22):2991-3005. PubMed ID: 15544485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Construction and application of pharmacophore model of benzoylurea derivatives as beta-tubulin inhibitors].
    Gao LM; Zhang SH; Yi H; Jiang JD; Song DQ
    Yao Xue Xue Bao; 2010 Apr; 45(4):462-6. PubMed ID: 21355210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacophore generation, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on benzamide analogues as FtsZ inhibitors.
    Tripathy S; Azam MA; Jupudi S; Sahu SK
    J Biomol Struct Dyn; 2018 Sep; 36(12):3218-3230. PubMed ID: 28938860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of thiadiazoles and thiazoles targeting the Bcr-Abl T315I mutant: from docking false positives to ATP-noncompetitive inhibitors.
    Radi M; Crespan E; Falchi F; Bernardo V; Zanoli S; Manetti F; Schenone S; Maga G; Botta M
    ChemMedChem; 2010 Aug; 5(8):1226-31. PubMed ID: 20509136
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemical function based pharmacophore generation of endothelin-A selective receptor antagonists.
    Funk OF; Kettmann V; Drimal J; Langer T
    J Med Chem; 2004 May; 47(11):2750-60. PubMed ID: 15139753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and in vitro evaluation of 1,3,4-thiadiazol-2-yl urea derivatives as novel AChE inhibitors.
    Xue XJ; Wang YB; Lu P; Shang HF; She JX; Xia LX; Qian H; Huang WL
    Chem Pharm Bull (Tokyo); 2014; 62(6):524-7. PubMed ID: 24694376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three dimensional pharmacophore modeling of human CYP17 inhibitors. Potential agents for prostate cancer therapy.
    Clement OO; Freeman CM; Hartmann RW; Handratta VD; Vasaitis TS; Brodie AM; Njar VC
    J Med Chem; 2003 Jun; 46(12):2345-51. PubMed ID: 12773039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel GSK-3beta inhibitors from sequential virtual screening.
    Kim HJ; Choo H; Cho YS; No KT; Pae AN
    Bioorg Med Chem; 2008 Jan; 16(2):636-43. PubMed ID: 18006321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombospondin peptides are potent inhibitors of mesangial and glomerular endothelial cell proliferation in vitro and in vivo.
    Hugo CP; Pichler RP; Schulze-Lohoff E; Pröls F; Adler S; Krutsch HC; Murphy-Ullrich JE; Couser WG; Roberts DD; Johnson RJ
    Kidney Int; 1999 Jun; 55(6):2236-49. PubMed ID: 10354272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microwave-Assisted Facile Synthesis, Anticancer Evaluation and Docking Study of N-((5-(Substituted methylene amino)-1,3,4-thiadiazol-2-yl)methyl) Benzamide Derivatives.
    Tiwari SV; Siddiqui S; Seijas JA; Vazquez-Tato MP; Sarkate AP; Lokwani DK; Nikalje APG
    Molecules; 2017 Jun; 22(6):. PubMed ID: 28617341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and anticonvulsant evaluation of some novel 2,5-disubstituted 1,3,4-thiadiazoles: pharmacophore model studies.
    Rajak H; Behera CK; Pawar RS; Singour PK; Kharya MD
    Acta Pol Pharm; 2010; 67(5):503-10. PubMed ID: 20873418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacophore modeling and virtual screening for designing potential 5-lipoxygenase inhibitors.
    Aparoy P; Kumar Reddy K; Kalangi SK; Chandramohan Reddy T; Reddanna P
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1013-8. PubMed ID: 20045317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A common feature-based 3D-pharmacophore model generation and virtual screening: identification of potential PfDHFR inhibitors.
    Adane L; Bharatam PV; Sharma V
    J Enzyme Inhib Med Chem; 2010 Oct; 25(5):635-45. PubMed ID: 19995305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel BACE1 inhibitors with a non-acidic heterocycle at the P1' position.
    Suzuki K; Hamada Y; Nguyen JT; Kiso Y
    Bioorg Med Chem; 2013 Nov; 21(21):6665-73. PubMed ID: 23993670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.